Explore more publications!

Oman Healthcare News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Healthcare News.

Press releases published on November 26, 2025

Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Silexion Therapeutics to Present at Noble Capital Markets' 21st Annual Emerging Growth Equity Conference
BioNTech informiert über Fortschritte im Rahmen des Umtauschangebots für CureVac-Aktien und weist auf Ablauf des Angebots am 3. Dezember 2025 um 15 Uhr MEZ hin
Altimmune to Participate in the Piper Sandler 37th Annual Healthcare Conference
Repligen Corporation to Present at Evercore Healthcare Conference
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference
CG Oncology Announces New Board Member and Board Transition
Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025
RTOERO calls for seniors strategy and care tailored to aging Ontarians at Queen’s Park
Herantis Pharma announces successful completion of six-month GLP toxicology study of HER-096
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference
Can-Fite’s Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference
Scilex Holding Company Announces Closing of Previously Announced Second Tranche Investment in Datavault AI Inc., Completing Its Two-Tranche Equity Financing in Datavault AI Inc.
Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of TGM-312, a Novel Investigational RNAi MASH Candidate
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions